See the promising research and results to date
In partnership with some of the world’s top researchers, ProtoKinetix has conducted more than a decade of laboratory testing throughout Europe and North America. Our proprietary anti-aging glycopeptide, AAGP®, has gone through a series of pre-clinical studies and is being evaluated in a clinical setting, and the results have been extremely promising. Learn about our research protocols and the potential we see for AAGP®.
Explore our research
What does the research show?
ProtoKinetix is proudly patented for the use of AAGP® in a variety of clinical research applications.
Since 2005, AAGP® has gone through international laboratory testing conducted by some of the top researchers in the world. See their scientific contributions.
Create a secure online account
Sign up to review research reports and company information not yet released to the general public.
Contact the team at ProtoKinetix to learn more about AAGP®’s performance in research studies.